Related Experiment Video

Updated: Jul 7, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.1K

Canadian Consensus Recommendations for the Management of Operable Stage II/III Non-Small-Cell Lung Cancer: Results of

James Tankel1, Jonathan Spicer1, Quincy Chu2

  • 1Department of Thoracic Surgery, McGill University Health Center, Montreal, QC H3G 1A4, Canada.

Current Oncology (Toronto, Ont.)
|December 22, 2023
PubMed
Summary

Experts developed consensus statements for treating stage II/III non-small-cell lung cancer (NSCLC). These guidelines aim to assist clinicians in managing NSCLC diagnosis and treatment across all stages.

Keywords:
Delphiconsensus guidelinesimmunotherapylung cancerneoadjuvantnon-small-cell

More Related Videos

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.5K
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

5.7K

Related Concept Videos